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Abstract approved: 
Coniine, an alkaloid from Conium maculatum, is a known  
teratogen in many domestic species with maternal ingestion  
resulting in arthrogryposis (twisted limbs) of the offspring.  
Arthrogryposis is also a common teratogenic outcome in  
humans but the mechanisms remain largely unknown. Therefore,  
the overall objectives of this thesis were 1) to develop an  
experimental model of coniine-induced arthrogryposis using  
a laboratory animal and 2) to use the experimental laboratory  
animal model to design and perform mechanistic studies to  
better understand mechanisms of arthrogryposis.  Coniine-
induced teratogenicity was evaluated in Sprague-Dawley  
rats, New Zealand white rabbits, and New Hampshire X White  
leghorn chicks.  Fetal weights were significantly lower in  
coniine-exposed rat and rabbit fetuses but the only  
statistically significant treatment-related visceral or  
skeletal malformation was a reduction of cranial ossification  
of rabbit fetuses.  Coniine-exposed rabbit litters were  
affected by arthrogryposis more than controls (2/6 vs. 0/9)  
Redacted for Privacywith the lesion characterized as hyperflexion of the  
antebrachial-carpal joint with supination.  Chicks treated  
with coniine showed a dose-dependent teratogenic response  
of excessive flexion or extension of one or more toes.  
Coniine caused malformations in the chick similar to those  
caused by nicotine and there was a statistically significant  
(P s 0.01) decrease in movement in coniine and nicotine  
sulfate treated chicks as determined by ultrasound.  
Control chicks were in motion an average of 33.67% of the  
time while coniine (1.5%) treated chicks were only moving  
8.95% of a 5 minute interval and no movement was observed  
for nicotine sulfate (5%) treated chicks.  Neither the  
peripheral nicotinic receptor antagonist d-tubocurarine  
chloride nor the central nicotinic receptor antagonist  
trimethaphan camsylate blocked the teratogenesis of 1.5%  
coniine in chicks.  The IC50 for coniine binding to  
nicotinic receptors in the rat was 31411M while that for the  
chick was 70vM.  
The chick embryo provides a reliable and simple  
experimental animal model of coniine-induced arthrogryposis.  
The data in this thesis support the hypothesis that the  
mechanism of coniine-induced teratogenesis is blockade of  
the nicotinic receptor.  Differences in the receptor  
affinity for coniine between susceptible and nonsusceptible  
species may explain, in part, cross-species variation in  
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INTRODUCTION  
Limb development, including joint formation, is a  
complex and poorly understood process.  Bones and joints are  
self differentiating structures that have critical periods  
of development which are susceptible to damage (Gardner  
1971).  Mechanistically defined models of abnormal joint  
formation could be very useful in understanding normal joint  
formation.  Although arthrogryposis ("twisted limbs") is a  
common teratogenic outcome in both livestock and humans, the  
mechanisms of arthrogryposis in the majority of these human  
and animal conditions remain largely unknown although viral- 
and plant-induced arthrogryposis have been documented.  
In 1988 it was estimated that poisonous plants cost the  
livestock industry more than $250 million annually (Nielsen  
1988).  This includes death loss as well as decreased  
reproductive efficiency.  Maternal ingestion of Conium  
maculatum (poison hemlock, CM) causes limb malformations in  
cattle (Keeler and Balls 1978), pigs (Panter, et al. 1985a),  
goats (Panter, et al. 1990), and sheep (Panter, et al.  
1988a).  Coniine, a major piperidine alkaloid of CM,produces  
arthrogryposis in cattle (Keeler 1974), but hamsters (Panter  
1983) and rats are not susceptible and rabbits only weakly  
susceptible (Forsyth and Frank 1993) to coniine-induced  
teratogenesis.  The mechanism of CM-induced malformations in  2 
livestock is unknown, as is the reason for the variation in  
species susceptibility to coniine, although a great deal is  
known concerning the nicotinic effects of coniine in terms  
of acute intoxication.  
Therefore, the overall objectives of this thesis are:  
1) to develop an experimental model of arthrogryposis using  
a laboratory animal, and 2) to use the experimental  
laboratory animal model to design and perform mechanistic  
studies aimed at better understanding mechanisms of  
arthrogryposis.  Coniine was evaluated in several laboratory  
animal species using routine teratology studies and due to  
the severe teratogenic response of the chick to nicotine,  
coniine was also evaluated for teratogenicity in the chick.  
Coniine caused malformations and lethality in the chick in a  
dose-dependent manner providing a reliable and reproducible  
model with which to study coniine-induced arthrogryposis.  
This model was subsequently used to determine  
histopathological changes induced by coniine, to test  
mechanistic hypotheses by comparison with chemicals that  
have similar and dissimilar mechanisms of action to coniine,  
and to study interspecies differences to coniine  
susceptibility.  3 
REVIEW OF LITERATURE  
Limb and Joint Formation  
Limbs are self differentiating structures which do not  
begin to form until the primordia of most organs have formed  
and the body wall musculature is well differentiated.  In  
humans, the fore limb buds appear on day 25 and hind limb  
buds on day 28 of gestation (Szabo 1989).  Other animals  
vary greatly in the appearance of limb buds during  
gestation: rats d10 and dll (approximately 48% of  
gestation), rabbits d10 and d10 (32% of gestation), and  
cattle d24 and d26 (approximately 9% of gestation) for fore  
and hind limb buds, respectively (Szabo 1989).  In the  
chick, wing and leg buds appear at stage 17 (about 60 hours  
or 12% of incubation, Hamburger and Hamilton 1951).  
Limb primordia arise close to the somites from a  
condensation of lateral plate mesoderm and its overlying  
ectoderm (Carlson 1988).  In the Drosophila embryo, the  
segment polarity gene wingless is involved in determining  
the positions along the antero-posterior axis of the embryo  
at which limb primordia will develop (Cohen 1990).  Similar  
genes are probably present in mammals.  As limb primordia  
grow off the body wall, ectoderm covering the tip of the bud  
thickens to form the apical ectodermal ridge (AER, Carlson  
1988).  The AER acts to stimulate outgrowth of the bud and  
to influence condensation of the mesenchyme at the center of  
the limb bud by a mechanism called centripetal packing  4 
(Wilson 1986).  The outer cell layer of the resulting core  
forms fibrous connective tissue while the inner mesenchymal  
cell layer forms cartilage.  At the distal aspect of the  
limb bud, aggregates of cells are formed which are called  
digital rays (Carlson 1988).  These will become digits as  
the tissue between them is eliminated via apoptosis (Hurle  
and Ganan 1986).  
Certain homeobox genes are transcribed within the limb  
bud coincident with precartilage differentiation.  
Precartilage condensation in the chick limb is divided along  
the proximodistal axis by the Hox-1 genes but cells  
undergoing chondrogenic differentiation cease expression of  
these genes (Yokouchi, et al. 1991; Rogina, et al. 1992).  
The branching process of precartilaginous condensations  
coincides with expression of Hox-4 genes (Yokouchi, et al.  
1991) which also act to maintain positional signalling along  
the antero-posterior axis of the limb (Nohno, et al. 1991).  
As mesenchymal cells differentiate into chondroblasts, the  
crucial stage of chondrogenic condensation coincides with a  
marked increase in cytoplasmic type II collagen mRNA.  The  
newly differentiated chondroblasts now produce type II  
collagen and cease producing type I collagen through  
transcriptional regulation (Kosher, et al. 1986).  
Spacial patterning of limbs is also influenced by  
gradients of morphogens such as retinoic acid and its  
analogues (Thaller and Eichele 1990).  One retinoic acid  
analog, 13-cis-retinoic acid, has been shown to act as a  5 
morphogen at low doses by enhancing cartilage production or  
a teratogen at high doses by depressing or eliminating  
cartilage development (Kwasigroch and Bullen 1991) in mouse  
limb buds.  The effects of retinoic acid are mediated by  
gradients of cellular retinoic acid binding proteins (CRABP)  
and retinoic acid receptors (RAR).  In the mouse, RARa and y  
transcripts are uniformly distributed along the limb bud on  
day 10 post-coitus, however CRABP transcripts are  
differentially expressed along a proximo-distal gradient.  
Later in development, RARy becomes specific to  
differentiating cartilage and skin cells and RARI3  
concentrates in the interdigital mesenchyme (Dolle, et al.  
1989).  Studies with limb regeneration in the adult newt  
(Giguere, et al. 1989) indicate that the morphogenic  
gradient is established through differential activation of  
pre-existing RAR's rather than differential gene expression.  
At the joint region, type I collagen predominates and  
there is a decrease in keratan-sulfate-containing  
proteoglycans (Craig, et al. 1987).  Cavitation begins after  
the form of the joint is established and the joint region  
represents an area of localized weakness.  Shear forces  
generated by the musculature cause the formation of a hinge  
and the eventual separation of the cartilaginous elements  
(Craig, et al. 1987).  Movements of chick embryos correspond  
with joint formation.  Complete cavitation occurs on days  
10-11 for the hip and knee, days 12-13 for the ankle, and  
days 14-15 for the metatarsophalangeal and interphalangeal  6 
joints (Llusa-Perez, et al. 1988).  The cavity increases in  
absolute size while maintaining relative size (Gardner 1971)  
and by the end of the embryonic period, the form of the  
bones and joints resembles that of the adult (Gardner 1971).  
In humans, joint development begins at about 5-6 weeks and  
by 8 weeks there is movement of the limbs.  Limb motion is  
essential for normal joint development (Smith 1988, Llusa- 
Perez, et al. 1988).  
The final stage of limb development, besides growth, is  
ossification of the skeleton.  In humans, skeletal changes  
associated with abnormal joint formation caused by  
neuromuscular disease include bone thinning leading to  
fractures and calluses but not major structural defects in  
bone (Rodriguez, et al. 1988).  Bone is produced from the  
cartilaginous precursor by a mechanism known as  
endochondrial ossification.  Mineralization is initiated by  
production of extracellular matrix vesicles which arise from  
either pinching off of the cytoplasmic membrane or as  
apoptotic bodies of dying chondrocytes (Anderson 1989).  
Matrix vesicles serve as the initial site of calcification  
and contain high concentrations of calcium binding  
phospholipids and alkaline phosphatase.  Within the matrix  
vesicle membrane, calcium and phosphate combine to form  
crystals of hydroxyapatite (HA) which protrude through the  
vesicle membrane.  Exposure of HA to the extravesicular  
environment leads to rapid proliferation of extracellular HA  
(Anderson 1989).  Osteoblasts enter the developing bone with  7 
the invasion of blood vessels (Carrington and Reddi 1991)  
and use these seed crystals of HA to lay dawn osteoid.  The  
process of ossification is accompanied by degradation of  
cartilage and production of type I collagen (Carrington and  
Reddi 1991) and is stimulated by proteins such as bone  
morphogenic protein (Carrington, et al. 1991a; Lyons, et al.  
1990).  
Arthrogryposis  
Limb malformations, including arthrogryposis ("twisted  
limbs"; persistent flexure or contracture of a joint), are  
among the most common malformations in humans and animals.  
One in 200 human infants is born with dislocated hips, one  
in 500 has clubfoot, and one in 3000 is born with multiple  
contractures (Hall 1989).  The spontaneous occurrence of  
arthrogryposis per 1000 live births in rats, rabbits, and  
cows is 0.03, 5.8, and 0.2, respectively (Szabo 1989).  
Causes of arthrogryposis in humans and animals are  
varied.  Decreased intrauterine movement by human fetuses  
has been associated with arthrogryposis and may be induced  
by neuropathic agents, myopathic agents, abnormal connective  
tissue or joints, or decreased space in which the fetus can  
move (Hall 1989).  Causes of arthrogryposis in livestock  
include plants such as poison hemlock, locoweed, tobacco,  
and lupine, and viruses such as bluetongue, Akbane, bovine  
viral diarrhea, and equine encephalitis (Noden 1985).  
Arthrogryposis is also suspected to be hereditary in  8 
Charolais (Nawrot, et al. 1980) and Hereford (Shupe, et al.  
1967) cattle.  
Experimentally, arthrogryposis  has also been shown to  
be associated with decreased fetal movement.  In a classic  
study, Drachman and Coulombre (1962), induced arthrogryposis  
in chick embryos by infusion of d-tubocurarine.  They  
demonstrated that temporary paralysis of the chick in ova  
results in limb malformations.  Tendons from the limbs of  
these chicks were taut and resisted joint movement.  
Dissection of all the periarticular and intraarticular  
ligaments was required before joint movement returned.  Rat  
fetuses paralyzed by transuterine injections of curare also  
developed arthrogryposis (Moessinger 1983) but the limbs  
were not analyzed histopathologically to determine soft  
tissue involvement.  Lack of fetal movement may also be part  
of the pathogenesis of arthrogryposis induced by CM in  
livestock.  Panter, et al. (1990) observed fetal movements  
by ultrasound in pregnant goats gavaged with CM seed or  
plant.  Both treatments resulted in significant reduction of  
fetal movements and kids were born with arthrogryposis  
(fixed carpal joints and rigidity of hock, elbow, and stifle  
joints).  Fetal movement in pregnant ewes gavaged with CM  
was also shown by ultrasound to be greatly reduced.  
However, limb malformations of lambs were transient and  
resolved by 8 weeks post partum (Panter, et al. 1988b).  The  
exact mechanism of decreased fetal movement from maternal  
ingestion of CM and relation to arthrogryposis is unknown  9 
but may be due to interaction of coniine with the nicotinic  
receptor.  Neither kids nor lambs were examined for  
neurological or soft tissue defects and the relationship  
between the nicotinic receptor and joint malformation is  
unknown.  
Conium maculatum  
CM was introduced to North America from Europe and Asia  
and has now spread throughout most of the continent (Knight  
1987).  The plant can be found along roadsides, waterways,  
and edges of cultivated fields.  Botanical features allow  
ready identification of CM (Knight 1987, Kingsbury 1964).  
It is a 3-9 foot tall biennial herb with many branches, a  
hollow stem, and a whitish tap root.  Stems have irregular  
purple spots, especially near the base and leaves are  
fernlike, compound, and triangular.  Small white flowers  
occur in umbrella-like clusters and produce pale brown  
seeds.  When crushed, stems, leaves, and roots emit a  
pungent, mousey odor.  
Domestic livestock as well as humans are susceptible to  
CM intoxication.  Poisonings by CM have been reported for  
rabbits (Short and Edwards 1989), tule elk (Jessup, et al.  
1986), turkeys (Frank and Reed 1987), dairy cattle (Galey,  
et al. 1992), horses, pigs, and goats (Panter, et al.  
1988c).  Human fatalities have occurred when CM is mistaken  
for edible plants such as wild carrot, parsley, or anise  
(Knight 1987).  Hemlock was used as a formal state poison in  10 
ancient Greece and Italy and an extract of CM was used to  
kill Socrates who denounced established gods (Kingsbury  
1964; Kennedy and Grivetti 1980).  Coturnism, or poisoning  
by toxic quail, has been blamed on hemlock seeds which were  
fed on by European migratory quail but a definitive link has  
not been established (Kennedy and Grivetti 1980; Frank and  
Reed 1990).  However, coniine (an alkaloid from CM) was  
found in the urine of 8 people after ingestion of small  
birds (skylarks, chaffinches, or robins) which had eaten  
hemlock buds prior to being killed.  These patients also had  
rhabdomyolysis and acute tubular necrosis (Rizzi, et al.  
1989).  
Five piperidine alkaloids isolated from CM have been  
associated with acute intoxication: coniine, gamma-
coniciene, N-methylconiine, conhydrine, and pseudoconhydrine  
(Keeler 1977).  Coniine and gamma-coniciene, the major toxic  
and teratogenic alkaloids, gradually increase and become  
predominant in seeds as the plant matures (Kingsbury 1964;  
Knight 1987).  
Coniine  
Coniine, a piperidine alkaloid, (Fig. 1) is derived  
from acetate (Leete 1963).  The compound is a colorless,  
alkaline,liquid at room temperature with a density of 0.85  
g/ml and a boiling point of 166°C.  Coniine has a distinct  
mouse-like odor and was the first alkaloid isolated from CM.  11 
The effects of coniine are similar to nicotine both  
centrally and peripherally.  Toxic action of coniine is  
biphasic with first stimulation then depression of the  
autonomic ganglia.  Coniine also causes end-plate  
depolarization unrelated to nicotinic receptor blockade  
(Bowman and Sanghvi 1963).  Symptoms of acute poisoning  
include nervousness, fasiculations of skeletal muscles,  
clonic and tonic contractions of separate limbs and  
convulsions followed by weakened and slowed heart rate,  
coma, and death (Bowman and Sanghvi 1963; Kingsbury 1964;  
Knight 1987).  Coniine has been shown to block the patellar  
reflex and crossed extensor and flexor reflex in cats  
indicating action at the spinal cord (Bowman and Sanghvi  
1963).  The alkaloid readily penetrates cell membranes  
implicating extra- and intracellular sites of action (Bowman  
and Sanghvi 1963).  
CH, 
Fig. 1. Coniine  12 
Nicotinic receptors are distributed both centrally and 
peripherally and are distinguished structurally and 
pharmacologically (Maelicke 1992).  The receptor exists as a 
pentameric complex  (a2l3by  or a2136E)  in which the subunits 
vary during development and between tissues creating a 
multiplicity of subtypes.  For example, in embryonic or 
denervated muscle, nicotinic receptors contain a y  subunit 
while receptors from adult innervated muscle contain the 
subunit (Gilman, et al. 1990).  Subtypes of receptors occur 
depending upon the type of subunits present which account, 
in part, for ligand specificity. 
Livestock vary markedly in their susceptibility to  
coniine.  Cattle develop severe symptoms when dosed with 3.3  
mg/kg body weight PO, mares develop mild signs of  
intoxication at 15.5 mg/kg body weight PO, while sheep  
tolerate doses of coniine up to 44 mg/kg body weight PO  
(Keeler, et al. 1980).  Quail and chickens are affected at  
50 mg/kg body weight PO but turkeys respond to 100 mg/kg  
body weight PO (Frank and Reed 1990) for intoxication to  
become evident.  A single oral dose of CM seed of 1 g/kg  
body weight is lethal to swine (Cheeke 1985).  
Besides acute nicotinic effects, coniine is also  
teratogenic.  Although most arthrogryposis in cattle has  
been attributed to maternal ingestion of lupines, CM was  
implicated in an outbreak of limb malformations in Utah  
calves born to dams not exposed to lupines (Keeler 1974).  
Coniine was subsequently shown to produce arthrogryposis in  13 
calves (Keeler 1974) after maternal gavage during days 55-75  
of gestation at coniine levels (approximately 1.5 ml/day)  
that maintained slight signs of intoxication.  Two of 3  
calves were born with lateral rotation of front limbs,  
permanent front carpal flexure, and bowed rear limbs.  
Hereford cows gavaged with fresh CM material at various  
times during days 45-75 of gestation produced calves with  
arthrogrypotic lesions similar to those caused by coniine  
(Keeler and Balls 1978).  These defects were not reproduced  
by maternal forced inhalation of coniine in which freshly  
chopped CM or cotton saturated with 3 cc of coniine was  
placed in the bottom of a strap-on feed bag and bags placed  
on the animals for 20 hours each day during days 45-75 of  
gestation (Keeler and Balls 1978).  Edmonds, et al. (1972)  
reported intoxications and congenital malformations in a  
Missouri swine herd that had been allowed onto a pasture  
containing CM.  Skeletal malformations, including  
arthrogryposis and scoliosis, were subsequently induced in  
newborn pigs from gilts fed fresh CM seed or plant on days  
43-53 of gestation (Panter, et al. 1985a) at levels designed  
to maintain clinical signs of intoxication (approximately  
126 g seed/day or 1,296 g plant/day).  Cleft palate was also  
induced in newborn pigs from gilts fed seed or plant on days  
30-45 of gestation (Panter, et al. 1985b).  Pregnant goats  
gavaged with CM seed (130.3 g/day) or plant (387.3 g/day)  
produced kids with both arthrogryposis and cleft palate  
(Panter, et al. 1990).  Fetal movements of kids were shown  14a  
by ultrasound to be significantly reduced up to 12 hours  
after maternal treatment of CM seed and up to 5 hours after  
maternal treatment of CM plant on days 45-60 of gestation.  
The authors showed a direct correlation between severity of  
malformation at birth and duration of reduced fetal movement  
during gestation.  Reduction in fetal movement also occurred  
in pregnant ewes gavaged with 5-10 g CM/kg body weight on  
days 30-60 of gestation, however, all 7 lambs born with  
arthrogryposis appeared normal by 8 weeks post partum  
(Panter, et al. 1988b).  
Analogs of coniine have been tested for their  
structure/activity relationship to teratogenicity.  A double  
bond introduced between the nitrogen and C-1 does not alter  
activity.  However, the degree of saturation and the length  
of the side chain affects the activity of the compound.  The  
coniine analog with a fully unsaturated ring is not  
teratogenic and analogs with a side chain of less than three  
carbons do not have teratogenic activity (Cheeke and Shull  
1985).  Therefore, piperidine alkaloids with a fully  
saturated ring and a side chain a to the nitrogen and at  
least propyl in length have teratogenic activity.  
Summary  
In order for an animal model to be useful for human  
terata, several requirements must be met: 1) similarity in  
teratogenic outcome, 2) susceptibility to teratogens of  
similar structure, 3) comparable metabolic processes, and 4)  14b  
similar mechanism(s) of action (Keeler 1988).  The  
significance of this proposal is twofold.  First, limb  
malformations are common in humans.  Mechanisms in the  
majority of these human conditions remain largely unknown.  
Second, arthrogryposis, including CM-induced lesions, is a  
significant economic factor in the cattle industry.  
Development of this model system will add to our  
understanding of CM-induced teratogenesis in domestic  
species and mechanisms of arthrogryposis in nonhuman and  
human species.  15 
CONIINE DOSE RANGE FINDING STUDY  
IN RATS AND RABBITS  
Purpose:  The purpose of this study was to determine the  
maximum amount of coniine that could be given by gavage to  
rats and rabbits without causing death.  
In much of the previous work involving coniine  
teratogenesis in domestic species (Keeler, et al. 1980,  
Keeler 1974, Panter, et al. 1985a, and Panter, et al.  
1988a), animals were given an amount of coniine or CM  
necessary to cause marked clinical signs of intoxication  
and this dose was adjusted at each treatment to maintain  
maximum intoxication.  Therefore, a dose of coniine needed  
to be found that caused clinical signs, but not death, in  
rats and rabbits.  Using allometric equations, an  
arithmetically related dose was metabolically scaled  
(Schmidt-Nielsen 1984) for rats and rabbits from available  
estimates on exposures in cows (Keeler, et al. 1980).  
Background:  Allometry is the use of nonisometric scaling. 
Allometric equations are descriptive and used for relating 
a variable quantity to body size.  The general form of the 
allometric equation is y = aMhb  where a is the 
proportionality coefficient (intercept at unity), Mb is 
body mass, and b is the body-mass exponent (slope).  For 
placental mammals, a = 70 and b = 0.75 when scaling 
metabolic rate in relation to body mass.  For this 
experiment, the dose of coniine in cows was used to 16 
calculate a dose of coniine for rats and rabbits based on  
the minimum energy cost (MEC), or basal metabolic rate, of  
each animal.  For example, the MEC dose of coniine for the  
cow is the dose of coniine divided by the MEC of the cow.  
MEC dose is then multiplied by the rat or rabbit MEC to get  
a dose of coniine for that animal.  Because allometric  
equations are generalizations of expected variables, the  
calculated dosages of coniine were used as a starting  
reference only.  Adjustments were required to maintain  
coniine levels without resulting in death of the animal.  
Results:  The mathematically scaled doses of coniine for  
rats and rabbits were 23.7 mg/kg body weight and 10.6 mg/kg  
body weight, respectively, based on 3.3 mg/kg body weight  
in the cow (Keeler, et al. 1980).  The results of the range  
finding tests are given in Tables 1 and 2 for rats and  
rabbits, respectively.  Rats were treated for 3 days and  
rabbits for 5 days.  These correspond to 60% and 33% of the  
fetal period for the rat and rabbit, respectively, although  
the susceptible period for cows is only 8% of the total  
fetal period.  Mild signs of coniine intoxication for rats  
included head shaking, chewing motions, and lethargy while  
those for rabbits included chewing motions, drooping ears,  
and lethargy.  Signs in either species were never of the  
magnitude reported in domestic livestock unless the rat or  
rabbit died.  Based on preliminary studies in the rat,  
rabbits were treated 3 times daily in order to maintain  17 
higher levels of coniine in the body throughout the day  
instead of spiking every 12 hours or less.  On the basis of  
this study, doses of 25 mg coniine/kg body weight and 40 mg  
coniine/kg body weight were chosen for rats and rabbits,  
respectively.  18 
Table 1:  Results of coniine range finding in rats.  
Dose 
(mg/kg) 
S.I.D.  B.I.D.  T.I.D. 
150  killed 1 of 1 
after 1 dose 
not done  not done 
100  killed 1 of 1 
after 3 doses 
not done  not done 
75  killed 2 of 2 
after 2 doses 
not done  not done 
50  no deaths, 
signs in 1 of 
2 after 3 
doses 
killed 1 of 2 
after 4 doses, 
signs in 2 of 
2 after 6 
doses 
killed 2 of 2 
after 3 and 4 
doses, 
respectively 
40  not done  signs in 2 of 
2 after 6 
doses 
not done 
25  no deaths, no 
signs in 2 of 
2 after 3 
doses 
no signs in 2 
of 2 after 6 
doses 
signs in 2 of 
2 after 9 
doses 19 
Table 2:  Results of coniine range finding in rabbits.  
Dose  T.I.D.  
(mg/kg)  
120	  killed 1 of 1  
after 3 doses  
80	  killed 1 of 1  
after 3 doses  
60	  killed 1 of 1  
after 8 doses  
40	  signs in 2 of 2  
after 3 doses  
30	  no signs in 1 of  1  
after 15 doses  
20	  no signs in 1 of  1  
after 15 doses  
10	  mild signs in 2 of  
2 after 8 doses  20 
EVALUATION OF DEVELOPMENTAL TOXICITY  
OF CONIINE TO RATS AND RABBITS  
Carol S. Forsyth and Anthony A. Frank  
Abstract  
Conium maculatum (poison hemlock, CM) is teratogenic  
in several domestic species, presumably due to its  
piperidine alkaloids, including coniine.  Coniine has been  
verified to be teratogenic in cattle.  Coniine/CM  
teratogenicity culminates in production of arthrogryposis.  
The purpose of this study was to evaluate coniine-induced  
teratogenicity in two laboratory animal species, Sprague- 
Dawley rats and New Zealand white rabbits.  Pregnant rats  
were given coniine (25 mg/kg body weight) by oral gavage at  
8 hour intervals on gestation days 16-18.  Pregnant rabbits  
were given coniine (40 mg/kg body weight) by oral gavage at  
8 hour intervals on gestation days 20-24.  Rats were killed  
on day 19 and rabbits on day 29.  Fetuses were immediately  
removed, weighed, and examined for external abnormalities.  
Alternate fetuses were either stained for skeletal  
examinations with alizarin red-S or fixed in Bouin's  
solution for visceral examination.  Symptoms of maternal  
intoxication due to coniine administration were observed in  
both the rat and rabbit, and higher doses were uniformly  
lethal.  Rabbits treated with coniine appeared to lose more  
weight and eat less than controls but there was no  
statistically significant difference between groups.  Fetal  21 
weights were significantly lower in coniine-exposed rat and  
rabbit fetuses indicating fetotoxicity.  The only  
statistically significant treatment-related visceral or  
skeletal malformation was a reduction of cranial  
ossification of rabbit fetuses, probably related to  
maternal toxicity.  Coniine-exposed rabbit litters tended  
to be affected by arthrogryposis (no bony deformities noted  
on skeletal exam) more than controls (2/6 vs  0/9).  The  
lesion was characterized as hyperflexion of the  
antebrachial-carpal joint with supination.  While this was  
not statistically significant, this incidence rate was  
significantly (P < 0.01) increased when compared to  
historical controls.  This study indicates coniine is not  
teratogenic to rats and weakly teratogenic to rabbits.  The  
reason for the lack of sensitivity to teratogenicity in  
these laboratory animal species as compared to domestic  
species is currently unknown.  
Introduction  
Limb malformations, including arthrogryposis ("twisted  
limbs"), are among the most common malformations in humans  
and domestic species.  One in 200 infants is born with  
dislocated hips, one in 500 has club foot, and one in 3000  
is born with multiple contractures or arthrogryposis (Hall,  
1989).  Arthrogryposis is also a common teratogenic outcome  
in livestock and a significant economic factor in the  
cattle industry.  Arthrogryposis is suspected to be  22 
hereditary in Charolais (Nawrot, et al. 1980) and Hereford  
(Shupe, et al. 1967) cattle.  Non-heritable causes of  
arthrogryposis in livestock include toxic plants as well as  
viruses such as bluetongue, Akabane, bovine viral diarrhea,  
and equine encephalitis (Noden and de Lahunta 1985).  With  
respect to plant causes of arthrogryposis, Panter, et al.  
(1990) found goats and cattle are susceptible to Conium,  
Nicotiana, and Lupinus formosus.  Although Lupinus sp.  
(lupine) ingestion is believed to be the most common toxic  
plant etiology of arthrogryposis in livestock ("crooked  
calf disease"), maternal ingestion of Conium maculatum  
(poison hemlock, CM) also causes limb malformations in  
cattle (Keeler and Balls 1978), pigs (Panter, et al.  
1985a), goats (Panter, et al. 1990), and sheep (Panter, et  
al. 1988a).  Coniine, a major piperidine alkaloid of CM,  
has been shown to produce arthrogryposis in cattle (Keeler,  
et al. 1980).  Mechanisms of arthrogryposis in the majority  
of human and animal conditions remain largely unknown.  
Much of the difficulty in establishing mechanisms of  
arthrogryposis lies in the poor understanding of normal  
limb formation.  Bones and joints are self differentiating  
structures that have critical periods of development during  
which they are susceptible to damage.  By the end of the  
embryonic period, the form of the bones and joints  
resembles that of the adult (Gardner 1971).  In humans,  
joint development begins at about 5-6 weeks of gestation  
and by 8 weeks there is movement of the limbs which is  23 
essential for joint development (Smith 1988).  Decreased  
intrauterine movement by human fetuses has been associated  
with arthrogryposis and is suggested to be caused by either  
neuropathic agents, myopathic agents, abnormal connective  
tissue or joints, or decreased space in which the fetus can  
move (Hall 1989).  The detailed mechanisms of coniine-
induced malformations in livestock are unknown but may also  
be related to decreased fetal movement (Panter, et al.  
1990).  
The purpose of this study was to evaluate the  
potential of coniine-induced arthrogryposis in two  
laboratory animal species, Sprague-Dawley rats and New  
Zealand white rabbits, to provide a model system for the  
study of mechanisms of arthrogryposis in human and nonhuman  
species.  Development of this model system will add to our  
understanding of CM-induced teratogenesis in domestic  
species and mechanisms of arthrogryposis in general.  
Materials and Methods  
Chemicals  
Coniine and Bouin's solution were purchased from Sigma  
Chemical Co. (St. Louis, MO).  
Animals  
Pregnant, nulliparous Sprague-Dawley rats were  
obtained from Simonsen (Gilroy, CA).  Day zero of gestation  
was defined as the day sperm were present in the vaginal  
smear.  Rats were housed individually in wire-bottom cages  24 
with water and commercial rodent chow available ad libitum.  
Pregnant first-litter New Zealand white rabbits were  
obtained from Western Oregon Rabbit Co. (Philomath, OR).  
Day one of gestation was defined as 24 hours post coitus.  
Does were housed individually in wire-bottom cages with  
water and commercial rabbit chow available ad libitum.  
Maternal body weights and food consumption were measured on  
gestation day (GD) 10-19 for rats and GD 18-29 for rabbits.  
Treatment Protocol  
Pregnant rats were given 25 mg coniine (in corn  
oil)/kg body weight by oral gavage at 8 h intervals on GD  
16-18.  Control rats received 1 ml corn oil per 0.2 kg body  
weight.  Rabbits were given 40 mg coniine (in corn oil)/kg  
body weight by oral gavage at 8 h intervals on GD 20-24.  
Controls were given 0.5 ml corn oil alone per 1 kg body  
weight.  Dose and time of administration were metabolically  
and chronologically scaled (Schmidt-Nielsen 1984) from  
domestic species data in the literature (Keeler, et al.  
1980) in an effort to maximize the probability of a  
teratogenic outcome.  Pilot studies (data not included)  
indicated these doses were the maximum nonlethal dosages  
tolerated by the dams.  Mild symptoms of coniine  
intoxication, such as head shaking and tremors, were  
observed at these doses, especially in the rat.  The period  
of late gestation was chosen for both the rat and rabbit  
based on the susceptible period for CM-induced  
arthrogryposis in the cow (Keeler, et al. 1980).  Treatment  25 
of rats with coniine throughout organogenesis (days 6-15,  
preliminary studies; data not included) did not result in  
induction of arthrogryposis.  
Fetal Evaluation  
Rats were killed on GD 19 by barbiturate anesthesia  
followed by exsanguination.  Rabbits were killed on GD 29  
by injection of approximately 2 ml Buthanasia-D (Schering- 
Plough) into the marginal ear vein.  All fetuses were  
immediately removed from the uterus and surrounding  
membranes, weighed, and examined for external abnormalities.  
Alternate fetuses were placed in either 95% ethanol or  
Bouin's solution.  
Ethanol-fixed fetuses were stained with alizarin red-S  
as described by Taylor (1986) except that the integument  
was removed from the rabbit fetuses only.  Rat and rabbit  
fetuses were eviscerated and fat patches removed.  Fetuses  
were cleared in potassium hydroxide then transferred to  
glycerin for storage and examination.  
All fetuses fixed in Bouin's solution were examined for  
visceral abnormalities using the Staples (1974) technique.  
Statistical Analyses  
Maternal body weight gain and food consumption were  
evaluated by one-way analysis of variance (Siegel 1956).  
Differences between fetal weights were determined by nested  
analysis of variance (Healy 1972).  The incidence of any  
given fetal malformation between litters was analyzed by  26 
the Fisher Exact Probability Test (Siegel 1956).  The level 
of significance for all tests was P s 0.05. 
Results  
Signs of maternal intoxication due to coniine  
administration were observed in both the rat and rabbit.  
In the rat, head shaking and chewing motions, occasionally  
accompanied by mild tremors, were observed.  Lethargy was  
the only sign observed in the rabbit.  Signs subsided in  
both species within 30 minutes of treatment.  Higher doses  
of coniine produced severe tremors in both species similar  
to those reported for cattle (Keeler, et al. 1980), but  
only when preceding death of the animal.  Even at the doses  
given in this study, two rabbits died during treatment: one  
after 8 doses, the other after 11 doses.  Data from these  
animals were excluded from statistical evaluation.  
In addition to clinical signs of intoxication,  
maternal toxicity in teratology studies is also determined  
by reduction in food consumption and/or body weight of the  
dam (Khera 1984).  Although rabbits treated with coniine  
appeared to lose more weight and eat less than control  
rabbits, these differences were not statistically  
significant (Table 3).  The high degree of variation in the  
data is due to a few animals that stopped eating during  
treatment.  Rat maternal weight gain and feed consumption  
were not statistically significantly different between  27  
treated and control animals and those trends observed in  
rabbits were less apparent (Table 3).  
There were no statistically significant differences in  
the numbers of viable fetuses between control and coniine-
exposed rat or rabbit litters.  No dead fetuses were found  
in any of the control or coniine-exposed rat litters.  
However, 2 of 9 control and 3 of 8 treated rabbit litters  
contained dead fetuses although the number per litter was  
small (controls: 2 of 11 and 1 of 11; treated: 2 of 11,  1  
of 8, and 1 of 10).  All dead fetuses were excluded from  
further analyses.  
While fetal weights were significantly lower in  
coniine-exposed rat and rabbit fetuses (Table 3), skeletal  
and visceral morphology were only minimally affected by  
coniine exposure (Tables 4 and 5).  In skeletal examinations,  
the only statistically significant treatment related  
malformation was a reduction in cranial ossification of  
rabbit fetuses.  No skeletal anomalies in rats or visceral  
abnormalities in either species were found to be  
statistically significant or to show  any apparent trends.  
The only external malformation observed was  
arthrogryposis in rabbit fetuses.  This lesion was observed  
in 2 of 8 coniine-exposed litters with intralitter  
incidence rates of 1 of 9 and 2 of 9, respectively.  The  
lesion was hyperflexion of the antebrachial-carpal joint  
with excessive supination (Fig. 2).  The lesion was only  
modestly reducible at birth and returned to the original  28 
position following manipulation.  In two cases, the  
alteration was unilateral (involving the left forelimb in  
the first case and the right forelimb in the second case),  
while the third case was bilateral.  While the incidence of  
arthrogryposis in coniine-exposed rabbit litters was not  
statistically significant when compared to study controls  
(0 of 9 litters affected), it is statistically significant  
when compared to historical controls (see discussion).  
Discussion  
Coniine was fetotoxic, probably associated with  
maternal toxicity, in rats and rabbits as evidenced by a  
decrease in fetal weights (Black and Marks 1986; Khera  
1984) in both species.  At the doses administered in  
rabbits, coniine caused clinical signs of intoxication.  
Two deaths occurred at this dose and only marginally higher  
doses were uniformly lethal in both species.  The slight  
reduction in maternal weight gain of rats and greater  
weight loss and lower daily food consumption for rabbits,  
although not statistically significant, may further  
represent maternal toxicity.  Maternal toxicity has also  
been associated with delays in fetal ossification (Black  
and Marks 1986) and this could explain decreased cranial  
ossification observed in coniine-treated rabbits.  
Embryotoxicity, as measured by reduced litter size (data  
not included) or increased fetal death, was not observed.  29 
In order to classify coniine as a teratogen in the  
species tested, a statistically significant increase in a  
treatment-related, permanent structural alteration not  
associated with maternal toxicity should be demonstrated  
(Black and Marks 1986).  Coniine was clearly not  
teratogenic in rats as administered in the present study.  
The only potential evidence of coniine teratogenicity in  
rabbits was arthrogryposis in 2 of 8 litters. Arthrogryposis  
without skeletal malformations detectable by alizarin red-S  
is not unusual.  In humans, skeletal changes associated  
with arthrogryposis caused by neuromuscular disease include  
bone thinning leading to fractures and calluses (Rodriguez,  
et al. 1988) but not major structural defects in the bone.  
While the incidence of arthrogryposis was not a statistically  
significant effect when compared to study controls, the  
present data are statistically significant (P < .01) when  
historical control incidence data for rabbits are used  
(5.8/1000 live births; Szabo 1989).  However, unlike  
numerous domestic animal species, coniine did not induce a  
high incidence of arthrogryposis in rabbit litters and few  
animals within rabbit litters were affected (1 of 9 and 2  
of 9).  In short, coniine (as administered to rabbits in  
the present study) is, at worst, a weak teratogen at doses  
which induced marked maternal toxicity.  
The apparent lack of sensitivity to the teratogenic  
effects of coniine in laboratory animals is interesting  
given that coniine/CM is a potent teratogen in many  30 
domestic species.  Coniine is only weakly teratogenic in  
rabbits and not teratogenic in rats or mice (preliminary  
observations in our laboratory).  CM seed containing 51%  
coniine was not found to be teratogenic in Golden hamsters  
(Panter 1983).  Coniine has been shown to cause  
arthrogryposis in cattle (Keeler, et al. 1980) and  
ingestion of CM resulted in arthrogryposis in cattle  
(Keeler and Balls 1978), goats (Panter, et al. 1990), sheep  
(Panter, et al. 1988a), and pigs (Panter, et al. 1985a) as  
well as cleft palate in pigs (Panter, et al. 1985b) and  
goats (Panter, et al. 1990).  
In contrast to its species-specific teratogenicity, CM  
is uniformly acutely toxic to a wide range of species via  
the nicotinic effects of piperidine alkaloids.  Five  
piperidine alkaloids isolated from CM have been associated  
with intoxication: coniine, gamma-coniciene, N-methylconiine,  
conhydrine, and pseudoconhydrine (Keeler and Balls 1978).  
Coniine and gamma-coniciene, the major toxic and  
teratogenic alkaloids, gradually increase and become  
predominant in seeds as the plant matures (Fairbairn and  
Challen 1959).  Acute toxic action of coniine is biphasic  
with stimulation followed by depression of autonomic  
ganglia, neuromuscular junctions, and central nicotinic  
synapses.  Symptoms of acute poisoning include nervousness,  
fasiculations of skeletal muscles, clonic and tonic  
contractions of separate limbs, and convulsions followed by  31 
weakened and slowed heart rate, coma, and death (Bowman and  
Sanghvi 1963).  
The proposed mechanism of teratogenicity for coniine  
is via nicotinic receptor blockade resulting in decreased  
motion of the fetus (Panter, et al. 1990) although there is  
no direct proof for this supposition.  If correct, it seems  
likely given the cross-species conservation of nicotinic  
receptors, that coniine would be teratogenic in any species  
given an exposure resulting in significant access of  
chemical to the fetus.  We utilized the highest possible  
non-lethal dose of coniine in rats and rabbits and were  
unable to produce the marked teratogenic effects observed  
in domestic species. Potential reasons for this differential  
effect include differences in metabolism and distribution  
of the compound or a difference in nicotinic receptors.  
The validity of these explanations is unclear and remains  
to be tested.  
In summary, coniine is not teratogenic to rats and  
weakly teratogenic to rabbits.  Decreased cranial  
ossification and reduced fetal weights were observed due to  
fetal toxicity probably as a result of maternal toxicity.  
Sprague-Dawley rats and New Zealand white rabbits are not  
appropriate laboratory animals for a model of coniine-
induced arthrogryposis.  The reason for the resistance to  
teratogenicity in these laboratory animal species is  
unknown at this time.  32 
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authors thank Dr. Karen Timm for assistance in scaling.  Table 3:  Maternal weight gain, food consumption, and fetal weightsl.  
average daily 
weight gain 
average daily 
food consumption 
fetal weight 
control  coniine  control  coniine  control  coniine 
Rate  5.02 
± 3.07 
4.65 
± 1.87 
20.00 
± 2.49 
20.44 
± 1.12 
3.03 
± 0.74 
2.76 
± 0.49* 
Rabbit3  -23.33 
± 20.00 
-35.00 
± 23.90 
74.12 
± 40.33 
45.28 
± 48.76 
36.56 
± 9.72 
32.49 
± 13.30* 
1 Data in grams; mean ± S.D.  
2 Rat control litters n = 8; treated litters n  = 10.  
3 Rabbit control litters n = 9; treated litters n = 8.  
Mean of treated group significantly different than control, P s 0.05.  34 
Table 4:	  External anomalies in offspring exposed to  
coniine in utero*.  
Rae	  Rabbit2  
control	  coniine  control  coniine  
Flexed limbs  0/8  0/10  0/9  2/6  
Scoliosis	  0/8  0/10  0/9  1/7  
Umbilica hernia  1/7  0/10  0/9  1/7  
Edema	  0/8  1/ 9  0/9  0/8  
Cleft palate  0/8  0/10  0/9  1/7  
Data expressed as affected litters/normal litters.  The  
incidence of edema within the affected rat litter was  
1/4.  The incidence of any anomaly within an affected  
rabbit litter never exceeded 2/4.  
1 Rat control litter size = 8.1 ± 5.2; treated litter size  
= 9.6 ± 5.1 (mean ± S.D.).  
2 Rabbit control litter size = 8.4 ± 4.1; treated litter  
size = 6.6 ± 3.7 (mean ± S.D.).  35 
Table 5:	  Skeletal anomalies in offspring exposed to  
coniine in uterol.  
Rat  Rabbit  
control  coniine  control  coniine  
Rib anomalies2	  0/8  0/10  6/3  6/2  
Reduced ossification  
sternum  4/4  9/ 1  1/8  1/7  
cranium  4/4  2/ 8  1/8  5/3*  
phalanges  0/8  0/10  0/9  1/7  
1 Data expressed as affected litters/normal litters.  
2 Includes missing, extra, and wavy ribs.  
* Statistically different from control. P < 0.05.  36 
Fig. 2. Alizarin-red S stained forelimbs from day 29 rabbit  
fetuses.  The fetus from which the limb on the right was  
taken was exposed to 40 mg coniine/kg maternal body weight  
at 8 hour intervals on gestation days 20-24.  The fetus  
from which the limb on the left was taken was identically  
treated with corn oil vehicle.  Note the hyperflexion of  
the antebrachial-carpal joint with excessive supination in  
the exposed fetus.  37 
EFFECT OF CONIINE ON THE DEVELOPING CHICK EMBRYO  
Carol S. Forsyth, Anthony A. Frank,  
Barbara J. Watrous, and Andrea A. Bohn  
Abstract  
Coniine, an alkaloid from Conium maculatum (poison  
hemlock), has been shown to be teratogenic in livestock.  
The major teratogenic outcome is arthrogryposis, presumably  
due to nicotinic receptor blockade.  However, coniine has  
failed to produce arthrogryposis in rats or mice and is  
only weakly teratogenic in rabbits.  The purpose of this  
study was to evaluate and compare the effects of coniine  
and nicotine in the developing chick.  Concentrations of  
coniine and nicotine sulfate were 0.015%, 0.03%, 0.075%,  
0.15%, 0.75%, 1.5%, 3%, and 6% and 1%, 5%, and 10%,  
respectively.  Both compounds caused malformations and  
lethality in a dose-dependent manner.  All concentrations  
of nicotine sulfate caused some lethality but a no observed  
effect level for coniine lethality was 0.75%.  The  
malformations caused by both coniine and nicotine sulfate  
were excessive flexion or extension of one or more toes.  
No histopathological alterations or differences in bone  
formation were seen in the limbs or toes of any chicks from  
any group, however, extensive cranial hemorrhage occurred  
in all nicotine sulfate treated chicks.  There was a  
statistically significant (P s 0.01) decrease in movement  
in coniine and nicotine sulfate treated chicks as  38 
determined by ultrasound.  Control chicks were in motion an  
average of 33.67% of the time while coniine treated chicks  
were only moving 8.95% of a 5 minute interval and no  
movement was observed for nicotine sulfate treated chicks.  
In summary, the chick embryo provides a reliable and simple  
experimental animal model of coniine induced  
arthrogryposis.  Data from this model support a mechanism  
involving nicotinic receptor blockade with subsequent  
decreased fetal movement.  
Introduction  
Coniine is a major piperidine alkaloid of Conium  
maculatum (poison hemlock, CM).  In utero exposure to coniine  
has been shown to produce arthrogryposis in cattle (Keeler,  
et al. 1980) and ingestion of CM during gestation also causes  
limb malformations in cattle (Keeler and Balls 1978), pigs  
(Panter, et al. 1985a), goats (Panter, et al. 1990), and  
sheep (Panter, et al. 1988a).  The proposed mechanism of  
teratogenicity for coniine is via nicotinic receptor blockade  
resulting in decreased motion of the fetus (Panter, et al.  
1990).  Given the broad cross-species teratogenicity of  
coniine in domestic animals and the cross-species  
conservation of nicotinic receptors, it is interesting that  
hamsters (Panter 1983), mice, and rats are resistant to the  
teratogenic effects of coniine and rabbits are only weakly  
susceptible (Forsyth and Frank 1993).  The reason for  
teratogenic species sensitivity remains unknown at present.  39 
Because nicotine produces a more consistent and severe  
teratogenic response in the chick embryo (Landauer 1960)  
than the rat embryo (Slotkin, et al. 1987), we hypothesized  
that the chick embryo could provide an experimental animal  
model of coniine-induced arthrogryposis.  Such a model  
would be useful to specifically study the mechanisms of  
species sensitivity of coniine teratogenicity as well as  
providing a general model for mechanistic investigations  
into arthrogryposis.  The purpose of the present study was  
to evaluate and compare coniine- and nicotine-induced  
malformations in the chick.  
Materials and Methods  
Chemicals  
Coniine (97% purity by gas chromatography) and  
nicotine sulfate (40% solution) were purchased from Sigma  
Chemical Corp. (St. Louis, MO).  Coniine was diluted in  
corn oil and nicotine sulfate in 0.9% NaCl.  
Experimental Design  
Study 1 was designed to characterize the effects of  
coniine and nicotine on chick embryos.  Dosing schedule and  
chemical concentration ranges were determined from similar  
studies in the literature (Hosseini and Hogg 1991a;  
Drachman and Coulombre 1962).  Concentrations of coniine  
used were 0.015%, 0.030%, 0.075%, 0.150%, 0.75%, 1.50%,  
3.00%, and 6.00% and concentrations of nicotine sulfate  
used were 1.0%, 5.0%, and 10.0% (v/v).  Fertile chicken  40 
eggs from a New Hampshire X White leghorn cross were  
incubated in a Jamesway forced-draught incubator at 38°C  
for the entire experimental period.  Treatment solution  
application was modified from the method described by  
Hosseini and Hogg (1991a).  On days 6, 8, and 10 of  
incubation, a small hole was punched in the egg above the  
air cell and 50 µl of treatment solution was injected into  
the air space for absorption through the chorioallantoic  
membrane.  The hole was then sealed with glue.  These time  
periods correspond to Stages 29, 34, and 36, respectively  
(Hamburger and Hamilton 1952).  Chicks were removed from  
the shell on day 17 of incubation and examined grossly for  
external malformations.  Only live chicks were included in  
the malformation analysis.  
Study 2 was an ultrasonic analysis of embryonic  
movement and histopathologic analysis of coniine, nicotine,  
and vehicle treated chicks.  Each treatment group contained  
25 eggs.  Based on the results of study 1, 1.5% coniine and  
5% nicotine sulfate were chosen due to a consistently high  
rate of malformations.  Corn oil was used as the control  
for this study because a few malformations were observed in  
corn oil treated chicks from study 1 (no effect was seen in  
0.9% NaC1 treated chicks; see results).  
Ultrasonic and Histopathological Analyses  
Gray-scale real time sonography (Ausonics Microimager  
1000, Universal Medical, Bedford Hills, NY) was used to  
monitor chick embryo movements 1 hour after the third  41 
treatment (d10).  Preliminary studies indicated this was  
the time of maximum paralysis of coniine treated chicks  
(data not included).  For access to the embryo, a hole was  
cut in the shell above the air cell and the space filled  
with 0.9% NaCl.  The mechanical sector transducer was 7.5MHz  
with a 100mm scan depth.  Embryo localization was confirmed  
by identification of a fetal heart beat.  Real time images  
were stored on a videotape.  The percentage of time chicks  
were in motion was determined for a 5 minute interval  
without knowledge of treatment group.  Chicks in motion  
equal to or less than 10% of the 5 minute interval were  
defined as severely inhibited.  After ultrasonic evaluation,  
chicks were fixed in 10% neutral buffered formalin and  
legs, toes, and brains processed routinely for light  
microscopic evaluation.  Histopathological interpretation  
was performed without knowledge of treatment groups.  Only  
data from live chicks were included in the analysis.  
Statistics  
Differences in chick motion were evaluated by one-way  
analysis of variance with the level of significance P s 0.01.  
Results  
Coniine and nicotine sulfate caused malformations and  
lethality in chick embryos in a dose-dependent manner  
(Table 6).  Lethality occurred at all concentrations of  
nicotine sulfate tested with 38%, 67%, and 100% of chicks  
dying at 1%, 5%, or 10% nicotine sulfate, respectively.  A  42 
no effect level of coniine on chick lethality was found at  
0.75%.  Above this dose, a sharp dose-response was observed  
with 15%, 45%, and 100% of chicks dying at 1.5%, 3.0%, and  
6% coniine, respectively.  Corn oil alone (diluent for  
coniine) appeared to cause mild reduction in body size as  
compared with 0.9% NaC1 and decreased body size was  
commonly observed in both treatment groups although body  
weights and measurements were not obtained, prohibiting  
statistical comparison.  
Coniine and nicotine sulfate limb lesions were similar:  
excessive flexion or extension of one or more toes (Fig. 3).  
Malformations of the toes were reducible but returned to  
their original position following manual manipulation.  
None of the toes appeared specifically to be affected more  
than the others.  Malformations were observed at all doses  
of,coniine and nicotine sulfate tested (Table 6).  At 1%  
and 5% nicotine sulfate, 20% and 100% of chicks were  
affected, respectively.  Corn oil alone resulted in a 20%  
incidence of malformations.  Coniine caused malformations  
in 25%, 29%, 53%, 43%, 43%, 70%, and 100% of chicks at  
0.015%, 0.03%, 0.075%, 0.15%, 0.75%, 1.50%, and 3% coniine,  
respectively.  Nicotine treated chicks were generally more  
severely affected than coniine treated chicks.  The most  
severely affected nicotine treated chicks displayed some of  
the morphological symptoms of the crooked-neck dwarf lethal  
mutation: neck rigid, vertebra palpable, and hypotrophy of  
leg musculature; however, rigid legs and shortened upper  43 
beak were not observed (Landauer 1960; Romanoff 1972).  No  
histopathological alterations or differences in bone  
formation were seen in the limbs or toes of chicks from any  
group in study 2.  
Extensive cranial hemorrhage occurred in all nicotine  
sulfate treated chicks.  Microscopically, this hemorrhage  
surrounded the rhombencephalon with the most severe cases  
having hemorrhage within the fourth ventricle.  Mild  
hemorrhage was occasionally observed in coniine treated or  
control animals.  
There was a statistically significant (P s 0.01)  
decrease in movement in coniine and nicotine sulfate  
treated chicks (Table 7) as determined by ultrasound.  
Control chicks were in motion an average of 33.67% of the  
time while coniine treated chicks were only observed to  
move 8.95% of the 5 minute interval.  While coniine  
dramatically decreased the amount of movement observed,  
nicotine sulfate completely paralyzed all chicks (no  
movement was observed).  For coniine treated chicks, the  
incidence of severe motion inhibition (75%) closely  
approximated the incidence of malformations at this  
concentration: 70% malformations at 1.5% coniine (Table 7).  
Discussion  
Because of coniine's acute nicotinic effects, the  
mechanism of coniine teratogenicity is proposed as a  
nicotinic receptor blockade resulting in decreased motion  44 
of the fetus (Panter, et al. 1990), a general mechanism  
associated with arthrogryposis in humans (Hall 1989).  In  
this study, coniine caused malformations in chick embryos  
similar to those caused by nicotine sulfate and both  
compounds produced defects in a dose-responsive manner.  
Lack of complete paralysis in coniine treated chicks as  
compared to nicotine sulfate treated chicks correlates with  
the less severe arthrogrypotic effects of coniine.  The  
close similarity of degree of effect on fetal movement and  
incidence of malformation supports the hypothesis that  
coniine causes arthrogryposis via a reduction of fetal  
movement, most likely due to nicotinic receptor blockade.  
If coniine produces arthrogryposis by decreased movement  
secondary to nicotinic receptor blockade, the mechanism of  
marked teratogenic species specificity remains unknown.  
Possibilities include differences in nicotinic receptor  
kinetics and/or biotransformation pathways.  Studies are  
underway to evaluate these possibilities.  
The physical basis of coniine- and nicotine-induced  
malformations observed in this study is unknown.  Decreased  
intrauterine movement caused by either neuropathic agents,  
myopathic agents, abnormal connective tissue or joints, or  
decreased space in which the fetus can move has been  
associated with arthrogryposis (Hall 1989).  The limb  
malformations observed in coniine and nicotine treated  
chicks were not associated with histological alterations on  
d10 and bone shape appeared normal (gross observation) on  45 
d17.  Hosseini and Hogg (1991b) also reported no change in  
bone formation at d10 for paralysed chick embryos.  
Therefore, the malformations observed here may be due to  
tendon contracture, although the mechanism by which fetal  
movement would affect tendon structure remains unknown.  
Coniine and nicotine both produced lethality in a  
dose-responsive manner.  Cranial hemorrhage seen in  
nicotine treated chicks may be related to lethality as  
cotreatment with d-tubocurarine chloride reduced the  
severity of both hemorrhage and lethality but limb  
malformations were not reduced (data not included).  It  
should be noted that the mechanism by which nicotine would  
cause such a hemorrhage is unknown and marked increases in  
cranial hemorrhage were not observed with the higher  
concentrations of coniine that resulted in increased  
mortality.  In short, the relationship of the cranial  
hemorrhage and mortality remains unclear.  
In summary, the chick embryo provides a reliable and  
simple experimental animal model of coniine induced  
arthrogryposis.  Data from this model support a mechanism  
involving nicotinic receptor blockade with subsequent  
decreased fetal movement.  This model will be useful in  
determining why some species are resistant to coniine-induced  
arthrogryposis, information which could provide a better  
understanding of arthrogrypotic mechanisms in general.  46 
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Table 6:	  Dose response of lethality and malformation rates  
for coniine and nicotine sulfate treated chicks'.  
Chemical  Live  % Live  Malformed  %  
Chicks  Chicks2  Malformed  
Corn oil  25 of 20  100  5 of 20  20  
% Coniine  
25  0.015  8 of 8  100  2 of 8  
0.030  7 of  7  100  2 of  7  29  
0.075  7 of  7  100  4 of  7  53  
0.150  7 of  7  100  3 of  7  43  
0.750  7 of 7  100  3 of 7  43  
1.500	  47 of 53  89  33 of 47  70  
3.000  6 of 9  67  6 of 6  100  
6.000  0 of  9  0  --- - --
0.9% NaCl  9 of 9  100  0 of 9  0  
% Nicotine  
1.0  5 of 8  63  1 of 5  20  
5.0  9 of 27  33  9 of  9  100  
10.0  0 of  8  0  --- ---
' chicks treated with 50 µl of coniine or nicotine sulfate  
solution on days 6, 8, and 10; see Methods for details.  
only live chicks included.  47 
Fig. 3:	  Limb malformations on d17 of coniine and nicotine  
sulfate treated chicks. Chicks were treated with  
50 111 of either 0.9% NaC1 (upper left), 5%  
nicotine sulfate (upper right), corn oil (lower  
left), or 1.5% coniine (lower right) on days 6,  
8, and 10 of incubation.  48 
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Table 7.	  Malformation rate and depressed movement of d10  
chick embryos 1 hour after treatment with either  
coniine or nicotine sulfate'.  
Treatment  Time in motion  % Chicks  % Chicks with  
(%)2   Malformed	  Depressed  
Movement3  
Control  33.67 ± 5.81  20	  0  
75  1.5% Coniine  8.95 ± 7.84*  70  
5% Nicotine  0.00 ± 0.00  100  100  
chicks treated on days 6, 8, and 10; corn oil used for  
control; see text for details.  
per cent of 5 minute interval; mean ± S.D.; n = 25 per  
group.  
in motion s 10% of a 5 minute interval.  
significantly different from control group, P < 0.01.  
**significantly different from control and coniine groups,  
P < 0.01.  49 
CONIINE BINDING TO NICOTINIC RECEPTORS IN THE  
RAT AND CHICK  
Carol S. Forsyth, Anthony A. Frank, and Robert C. Speth  
Abstract  
Coniine, an alkaloid from Conium maculatum (poison  
hemlock), is a known teratogen in many domestic species  
with maternal ingestion resulting in arthrogryposis of the  
offspring.  We have previously shown that rats are not  
susceptible and rabbits only weakly susceptible to coniine-
induced arthrogryposis.  However, the chick embryo does  
provide a reproducible laboratory animal model of coniine-
induced teratogenesis.  The reason for this cross-species  
variation is unknown.  Because the proposed mechanism of  
coniine teratogenesis is interaction with nicotinic  
receptors, the purpose of this study was to evaluate  
coniine binding to nicotinic receptors in susceptible and  
nonsusceptible species.  Using the chick model, neither the  
peripheral nicotinic receptor antagonist d-tubocurarine  
chloride nor the central nicotinic receptor antagonist  
trimethaphan camsylate blocked the teratogenesis or lethality  
of 1.5% coniine (50 it /egg).  Trimethaphan camsylate  
enhanced coniine-induced lethality in a dose dependent  
manner.  Neither nicotinic receptor blocker prevented  
nicotine sulfate-induced malformations but d-tubocurarine  
chloride did block lethality in a dose-dependent manner.  
Coniine binding to nicotinic receptors isolated from rat  50 
diaphragm and chick leg muscle was also assessed.  The IC50  
for coniine binding in the rat was 314RM while that for the  
chick was 7ORM.  Overall, coniine displacement of  
bungarotoxin was low for both the rat and the chick  
compared to nicotine and  1-a-bungarotoxin binding alone  
was low in rat fetal thigh tissue.  Differences in receptor  
affinity and/or quantity between the rat and chick may  
explain, in part, the differences in susceptibility of  
coniine-induced teratogenesis between these two species.  
Introduction  
Coniine, an alkaloid from Conium maculatum (poison  
hemlock, CM), is a documented teratogen in many domestic  
species (Panter, et al. 1988c).  The acute toxic action of  
coniine is biphasic with first stimulation then depression  
of,the autonomic ganglia (Bowman and Sanghvi 1963).  
Similarly depression, or blockade, of nicotinic receptors  
resulting in reduced fetal movement is the proposed  
mechanism of teratogenic action of coniine (Panter, et al.  
1990).  Evidence consistent with this hypothesis is  
supported by the reduction in fetal movements and similar  
malformations observed in CM treated goat kids (Panter, et  
al. 1990) and in coniine and nicotine sulfate treated  
chicks (Forsyth, et al. 199x).  
While a teratogenic mechanism involving blockade of  
nicotinic receptors would seem likely to result in cross- 
species teratogenicity, coniine is teratogenic in several  51 
domestic species (Panter, et al. 1988c) and the chick  
(Forsyth, et al. 199x) but hamsters (Panter 1983) and rats  
(Forsyth and Frank 1993) are unaffected and rabbits are only  
minimally susceptible (Forsyth and Frank 1993).  The reason  
for this cross species variation in susceptibility to  
coniine-induced teratogenesis is unknown but may be due to  
differences in receptor affinity/number or biotransformation.  
Nicotinic receptors are distributed both centrally and  
peripherally and are distinguished structurally and  
pharmacologically (Maelicke 1992).  Using the chick model  
of coniine-induced teratogenesis, the first part of this  
study attempted to determine whether coniine-induced  
malformations and lethality are mediated through central or  
peripheral nicotinic receptors.  The central nicotinic  
receptor blocker trimethaphan camsylate and the peripheral  
nicotinic receptor blocker d-tubocurarine chloride (Gilman,  
et al. 1990) were evaluated for their ability to block the  
malformations and/or lethality caused by coniine and  
nicotine sulfate.  The competition binding curves of  
coniine and nicotine sulfate for nicotinic receptors  
isolated from rat diaphragm and chick leg muscle were  
compared to assess binding affinity and receptor quantity.  
Materials and Methods  
Chemicals  
Coniine, nicotine sulfate, and a-bungarotoxin were  
purchased from Sigma Chemical Corp (St. Louis, MO).  52 
Trimethaphan camsylate was purchased from Roche Laboratories  
(Nutley, NJ) and d-tubocurarine chloride from ICN  
125,- ,  Biochemicals (Irvine, CA).  [  II a-Bungarotoxin was  
purchased from New England Nuclear (Boston, MA).  
Experimental Design  
Nicotinic Receptor Blockers.  Study 1 determined the  
effects of central or peripheral nicotinic blockers on  
coniine-induced malformations and lethality in the chick.  
Fertile chick eggs from a New Hampshire X White leghorn  
cross were incubated in a Jamesway forced-draught incubator  
at 38°C.  Treatment solutions were applied as described  
previously (Forsyth, et al. 199x; Hosseini and Hogg 1991a).  
Briefly, a small hole was punched in the shell above the  
air cell on days 6, 8, and 10 of incubation and 50 R1 of a  
nicotinic receptor blocker followed by 50 R1 1.5% coniine  
or. 5% nicotine sulfate solution were injected into the air  
space.  The hole in the shell was then sealed with glue.  
Based on preliminary observations of 25% lethality or less,  
concentrations of d-tubocurarine chloride used were 2% and  
3% and of trimethaphan camsylate 0.6%, 1.2%, and 1.8% (v/v  
in 0.9% NaC1).  Numbers of chicks evaluated at each  
concentration are given in Figures 4 and 5.  On day 17 of  
incubation chicks were removed from the shell and examined  
for gross external malformations; only live chicks were  
included in the malformation analysis.  On d10 some chicks  
were remeved from the shell and fixed in 10% neutral  
buffered formalin and brains processed routinely for light  53 
microscopic evaluatuion.  Histopathological interpretation  
was performed without knowledge of treatment groups.  
Nicotinic Receptor Binding.  Study 2 was designed to  
measure coniine binding to nicotinic receptor preparations  
from muscle from chicks and rats.  Chicks, incubated as  
described above, were euthanitized by placing at -20°C for  
several minutes on day 10 of incubation.  Thigh muscle was  
removed and frozen at -70°C until receptor isolation.  Rat  
diaphragm muscle was obtained from adult male Sprague- 
Dawley rats and used fresh.  Rats were anesthetized with  
Equithesin (Jensen-Salsbury, Kansas City, MO) then killed  
by exsanguination.  Diaphragm muscle end plate region was  
used to obtain a high concentration of nicotinic receptors.  
Attempts were made to determine the affinity of coniine for  
nicotinic receptors in rat fetal and adult thigh muscle.  
However, specific  [125-a-bungarotoxin binding in these  
tissues was too low to accurately measure coniine binding  
by this protocol (data not included; see discussion). Chick  
and rat tissues were homogenized for 10 seconds with a  
mechanical tissue homogenizer in 50mM Tris-HC1 (pH 7.4)  
containing 100mM NaC1 and 0.1mM phenylmethylsulfonylfluoride  
to inhibit proteolytic enzymes.  Homogenates were filtered  
through 4 layers of gauze and centrifuged at 3000g for 10  
minutes.  The supernatant was centrifuged at 48,000g for 20  
minutes.  The resulting pellet was resuspended in the above  
buffer at approximately 0.1 g initial wet weight of  
tissue/ml.  Tissue preparations (about 10 mg) were incubated  54 
with lOnM [1251] -a-bungarotoxin in the presence or absence  
of coniine or nicotine sulfate in 500 [1,1 of 50mM Tris-HC1,  
100mM NaC1 (pH 7.4 buffer).  After 2 hours at room  
temperature, the reaction was stopped by addition of 3 ml  
of room temperature 50mM sodium-potassium phosphate buffer,  
pH 7.4, and immediately filtered through a Schleicher and  
Schuell #32 glass filter which had been previously soaked  
with 1 mg/ml bovine serum albumin.  Filters were rinsed 2  
additional times with 50mM sodium-potassium phosphate  
buffer and the filter bound radioactivity determined by  
Specific [ 125I]-a-bungarotoxin  gamma scintillation counting.  
binding to nicotinic receptors was defined as binding that  
was displaced by 0.1mM d-tubocurarine chloride.  
Statistics  
The incidence of coniine- or nicotine sulfate-induced  
lethality or malformations in the presence or absence of a  
nicotinic receptor blocker was calculated using the chi- 
square analysis with the level of significance P s 0.05.  
IC50 values of competing ligands for [125I]-a-bungarotoxin  
binding were derived using Inplot (Graph Pad Software, San  
Diego, CA) based on the equation: Y = 1-(I/(I+IC50)) where  
Y is the fraction of binding in the absence of competing  
ligand and I is the concentration of competing ligand.  
Average IC50 values for 2 assays are reported.  55 
Results  
Neither d-tubocurarine chloride nor trimethaphan  
camsylate blocked the teratogenicity or lethality of 1.5%  
coniine (Fig. 4).  Trimethaphan camsylate actually enhanced  
coniine induced lethality in a dose responsive manner with  
statistically significant differences at 1.2% and 1.8%.  
Nicotine sulfate-induced malformations were unaffected by  
either d-tubocurarine chloride or trimethaphan camsylate  
(Fig. 5).  Trimethaphan camsylate did not block the lethality  
of 5% nicotine sulfate.  D-tubocurarine chloride did block  
lethality of 5% nicotine sulfate in a dose dependent manner  
with a statistically significant difference only at the  
highest d-tubocurarine chloride concentration tested (3%).  
Intracranial hemorrhage seen in nicotine sulfate treated  
chicks (Forsyth, et al. 199x) may be related to lethality  
as d-tubocurarine chloride also reduced the  severity of  
this hemorrhage microscopically (data not included).  
Trimethaphan camsylate alone did not cause any malformations  
in chicks at any concentration tested up to 5% which  
resulted in 100% lethality.  Twenty-five per cent lethality  
was observed at a concentration of 1.8% trimethaphan  
camsylate, the highest concentration used as a blocker with  
coniine (data not included).  Malformations, similar to  
those observed with nicotine sulfate alone, occurred for 2%  
and 3% d-tubocurarine chloride at rates of 20% and 80%,  
respectively and 3% d-tubocurarine chloride alone resulted  
in 14% lethality (data not included).  56 
Nicotinic receptors from both rat diaphragm and chick  
leg muscle bound coniine with lower affinity than nicotine  
sulfate (Figs. 6 and 7).  The average IC50 for coniine  
125-, displacement of specific  l] a-bungarotoxin binding to  
nicotinic receptors from chick muscle was 70RM and from rat  
diaphragm 314RM.  This was considerably less than the  
IC50's for nicotine, 3.5RM and 25RM for chick muscle and  
rat diaphragm, respectively. Coniine displaced approximately  
125-, 12,000 - 9000 cpm of  i] a-bungarotoxin from rat  
diaphragm muscle over a concentration range of 1.26RM to  
1.26mM while nicotine displaced 14,000 - 10,000 cpm over a  
concentration range of 0.04RM to 0.4mM (Fig. 6).  Total  
[1251]-a-bungarotoxin displacement from chick muscle was  
approximately 10,000 cpm to 7500 cpm for 1.26RM - 1.26mM  
coniine and 11,250 cpm to 8000 cpm for 0.04RM - 0.4mM  
nicotine (Fig. 7).  
Discussion  
Using the chick model of coniine-induced teratogenesis,  
we were unable to block the effects of coniine and nicotine  
sulfate using central and peripheral nicotinic receptor  
antagonists.  Because of the complicated nature of the  
interaction of nicotine sulfate and coniine with the  
nicotinic receptor (stimulation and blockade), the failure  
of the antagonists to prevent the teratogenic effects does  
not necessarily imply that the terata are not mediated by  
an effect at the nicotinic receptor, particularly given  57 
existing data that support a role for the nicotinic receptor  
(Panter, et al. 1990; Forsyth, et al. 199x).  If the  
teratogenic effects of coniine had been blocked by the  
antagonists, this would have provided direct evidence for  
the involvement of the nicotinic receptor.  However, due to  
the biphasic response of the receptors to coniine with  
first stimulation then depression or blockade (Bowman and  
Sanghvi 1963), failure of the antagonists to block coniine  
effects is difficult to interpret.  Also, the 100% rate of  
malformations induced by 5% nicotine sulfate alone may have  
masked any synergistic effects of the blockers.  Teratogen  
concentrations were fixed such that a high malformation  
rate would occur allowing detection of even modest  
protection by the blockers.  
Central and peripheral nicotinic receptor antagonists  
were also not definitive in determining the relationship of  
coniine binding to lethality.  Nicotine sulfate induced  
lethality appears to be due to interaction of peripheral  
nicotinic receptors whereas coniine induced lethality appears  
to involve central nicotinic receptors (Figs. 4 and 5).  
The basis for this apparent difference is unknown.  Further,  
why a peripheral nicotinic receptor antagonist would  
decrease intracranial hemorrhage is also unclear.  In  
short, the relationship between coniine-induced lethality,  
intracranial hemorrhage, and the peripheral nicotinic  
receptor in the chick embryo is uncertain and deserves  
further study.  58 
Differences in receptor binding of coniine may be one  
factor in the cross-species variation of susceptibility to  
coniine-induced teratogenesis.  The IC50 for coniine  
binding in the rat, a nonsusceptible species, was greater  
than 4 times that of the chick, a susceptible species.  
Thus, while coniine is presumably acting through muscular  
nicotinic receptors (Forsyth, et al. 199x), it appears to  
do so with a lower affinity than nicotine.  If species  
susceptibility is related to nicotinic receptor affinity,  
nicotine should be more teratogenic than coniine in the  
chick and both nicotine and coniine should be stronger  
teratogens in the chick than the rat.  We have previously  
shown that nicotine is a more potent teratogen in the chick  
than coniine (Forsyth, et al. 199x).  Nicotine has also  
been shown to cause more pronounced structural defects in  
the chick (Landauer 1960; Forsyth, et al. 199x) than in the  
rat (Slotkin, et al. 1980; Joschko, et al. 1991).  Coniine  
also causes pronounced defects in chicks (Forsyth, et al.  
199x) but not rat embryos (Forsyth and Frank 1993).  
Nicotinic receptors exist as a pentameric complex and  
the subunits vary during development and between tissues  
creating a multiplicity of receptor subtypes (Gilman, et  
al. 1990).  Subtypes of receptors occur depending upon the  
type of subunits present which account, in part, for ligand  
specificity.  The low amount of coniine binding as compared  
to nicotine sulfate binding that was observed for receptors  
from both the rat and chick (Figs. 6 and 7) may indicate a  59 
second high affinity site for coniine binding but we have  
not further characterized this binding.  
Differences in nicotinic receptor number/distribution  
could also play a role in interspecies differences in  
teratogenic susceptibility.  Chick thigh muscle was used in  
the present study, but fetal rat thigh muscle analysis was  
not possible due to low binding of  a-bungarotoxin.  
If peripheral nicotinic receptors are, in fact, decreased  
in the rat fetus as compared to chick, this would be  
expected to impart less coniine- and/or nicotine-induced  
paralysis in the rat fetuses resulting, in turn, in fewer  
terata.  A combination of decreased receptor affinity,  
possible subtypes, and fewer receptors seems likely based  
on the data presented in this study.  
In summary, both the peripheral nicotinic receptor  
antagonist d-tubocurarine chloride and the central nicotinic  
receptor antagonist trimethaphan camsylate failed to  
protect the chick embryo from coniine-induced teratogenesis.  
Differences in coniine binding to nicotinic receptors from  
rat diaphragm and chick leg muscle preparations may explain,  
in part, the cross-species variation in susceptibility to  
coniine-induced teratogenesis.  Investigations are underway  
to determine whether differences in biotransformation of  
coniine between rats and chicks also exists.  60 
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CONCLUSIONS AND FUTURE DIRECTION  
The Sprague-Dawley rat is not susceptible and the New  
Zealand white rabbit is only weakly susceptible to coniine-
induced arthrogryposis.  No coniine exposed rat litters  
(0/10) were malformed.  However, 2 of 8 coniine exposed  
rabbit litters contained fetuses with arthrogryposis,  
although few fetuses within litters were affected (1 of 9  
and 2 of 9).  While this litter incidence rate in rabbits  
is not statistically significant within this study, the  
fetal incidence rate is significant when compared to the  
historical control incidence of arthrogryposis in rabbits  
of 5.8/1000 live births (Szabo 1989).  Therefore, coniine  
is not teratogenic to rats and only weakly teratogenic to  
rabbits.  The reason for the resistance to teratogenicity  
in these laboratory animal species is unknown, but may be  
due to differences in metabolism and/or receptor kinetics.  
Nicotinic receptor binding by coniine and nicotine was  
investigated in the rat (see below) but metabolic  
differences in coniine biotransformation remain unknown.  
A statistically significant decrease in fetal weights  
of coniine-exposed rat and rabbit litters and a reduction  
of cranial ossification in coniine-exposed rabbit fetuses  
was observed.  These differences were probably due to  
fetotoxicity as a result of maternal toxicity and not a  
direct effect of coniine on the fetuses.  While maternal  
toxicity parameters of weight gain and feed consumption  65 
were not affected by coniine treatment, acute signs of  
intoxication were observed in both species immediately  
after dosing.  
Coniine and nicotine sulfate caused malformations and  
lethality in chick embryos in a dose-responsive manner.  
Limb malformations induced by both compounds were excessive  
flexion or extension of one or more toes.  Therefore, the  
chick embryo provided a reliable and simple experimental  
animal model of coniine-induced arthrogryposis.  Since the  
mechanism of coniine-induced teratogenicity is proposed as  
a nicotinic receptor blockade resulting in decreased fetal  
motion, this model was used to monitor fetal movements  
after coniine or nicotine treatment.  At the concentration  
of coniine (1.5%) used for this study, the incidence of  
malformations (70%) closely approximated the incidence of  
severe motion inhibition (75%).  Therefore, data from this  
model support a mechanism involving nicotinic receptor  
blockade with subsequent decreased fetal movement.  
The physical basis of coniine- and nicotine-induced  
malformations observed in the chick embryo is unknown.  
Limb malformations were not associated with histological  
alterations on d10 and bone shape appeared normal by gross  
observation on d17.  The lack of nervous, osseous, or  
articular changes in coniine or nicotine treated chicks is  
in accords with proximate tendinous/ligamentous contracture,  
although additional, more detailed microscopic studies will  
be required to confirm such alterations.  Also, how  66 
nicotinic receptor blockade and/or lack of fetal movement  
affects soft tissues is unknown.  
Differences in receptor affinity and/or quantity  
between the rat and chick may explain, in part, the species  
specificity of coniine-induced teratogenesis.  Nicotinic  
receptors from both the rat and chick bound coniine with  
lower affinity than nicotine.  The average IC50 for coniine  
displacement of specific  [125I]-a-bungarotoxin binding to  
nicotinic receptors from chick was 7ORM and from rat 314RM.  
These were considerably greater than the IC50's for nicotine,  
3.5RM and 25RM for chick and rat, respectively.  Therefore,  
while coniine is presumably acting through muscular nicotinic  
receptors, it appears to do so with a lower affinity than  
nicotine.  Differences in biotransformation of coniine  
between the rat and chick may also contribute to the  
differences in species susceptibility to coniine-induced  
teratogenesis, but remain to be investigated.  67 
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APPENDIX  
Dose Response Curves for Coniine, Nicotine Sulfate,  
d-Tubocurarine Chloride,  
and Trimethaphan Camsylate in the Chick  
Purpose:  The purpose of this experiment was to determine  
the dose/response relationship for lethality and  
malformation rate in chicks to coniine, nicotine sulfate,  
d-tubocurarine chloride, and trimethaphan camsylate.  These  
results were preliminary to using the chick model of  
coniine-induced teratogenesis for studying the mechanism of  
action of coniine (Chapter 5).  Coniine is a nicotinic  
alkaloid, therefore, nicotine was used as a positive  
control for comparison.  The central nicotinic receptor  
blocker trimethaphan camsylate and the peripheral nicotinic  
receptor blocker d-tubocurarine chloride were evaluated in  
subsequent experiments for their ability to block the  
lethality and/or malformations caused by coniine and  
nicotine sulfate (Chapter 6).  
Results:  Coniine, nicotine sulfate, and d-tubocurarine  
chloride caused lethality and malformations in chick  
embryos in a dose dependent manner.  No malformations were  
observed in chicks with trimethaphan camsylate but  
lethality occurred in a dose-dependent manner.  A no effect  
level for coniine on chick lethality was observed at 0.75%.  
Above this dose, a sharp dose response was observed with  
15%, 45%, and 100% of chicks dying at 1.5%, 3.0%, and 6.0%  74 
coniine, respectively.  Coniine caused malformations in  
25%, 29%, 53%, 43%, 43%, 70%, and 100% of chicks at 0.015%,  
0.03%, 0.075%, 0.15%, 0.75%, 1.50%, and 3.0% coniine,  
respectively (Fig. 8).  Lethality occurred at all  
concentrations of nicotine sulfate tested with 38%, 67%,  
and 100% of chicks dying at 1%, 5%, and 10% nicotine  
sulfate, respectively.  At 1% and 5% nicotine sulfate, 20%  
and 100% of chicks were malformed, respectively (Fig. 9).  
A no effect level of d-tubocurarine chloride on chick  
lethality was observed at 2% but 14%, 75%, 71%, and 100% of  
chicks died at 3%, 4%, 5%, and 10% d-tubocurarine chloride,  
respectively.  Malformations were observed at all  
concentrations of d-tubocurarine chloride tested with 20%,  
83%, and 100% of chicks affected at 2%, 3%, and 4%,  
respectively (Fig. 10).  A no effect level for trimethaphan  
camsylate lethality was observed at 1.2% with 25%, 71%, and  
100% of chicks dying at 1.8%, 2.4%, and 5% trimethaphan  
camsylate, respectively (Fig. 11).  75 
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Fig. 8:  Lethality and malformations induced in the chick on  
d17 after coniine treatment on days 6, 8, and 10.  76 
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Fig. 9:	  Lethality and malformations induced in the chick  
on d17 after nicotine sulfate treatment on days 6,  
8, and 10.  77 
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Fig. 10: Lethality and malformations induced in the chick  
on d17 after d-tubocurarine chloride treatment on  
days 6, 8, and 10.  78 
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Fig. 11: Lethality induced in the chick on d17 after  
trimethaphan camsylate treatment on days 6, 8,  
and 10.  